Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07539545Not ApplicableNot Yet Recruiting

The Comparison Between M-E-BCS and C-O-BCS.

Role: collaborator

NCT07276919Phase 4Not Yet Recruiting

Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy

Role: collaborator

NCT06995118Not ApplicableRecruiting

The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction

Role: collaborator

NCT06606522Completed

A Clinical Diagnostic System for Intrinsic Acute Kidney Disease

Role: collaborator

NCT06379204Not ApplicableCompleted

A Study on the Intervention of Metabolic Syndrome Patients With Exercise Prescription Based on Ventilatory Threshold Using Cardiopulmonary Exercise Test

Role: lead

NCT05943184Not ApplicableCompleted

Cognitive Behavioral Nursing Model

Role: lead

NCT04313335Not ApplicableCompleted

Duloxetine for PHN

Role: collaborator

NCT03719820Unknown

Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )

Role: collaborator

All 8 trials loaded